Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinoma

American Journal of Pathology

Volumn 185, Issue 4, 2015, Pages 1022-1032

  Duconseil, Pauline ^a   Gilabert, Marine ^a   Gayet, Odile ^a   Loncle, Celine ^a   Moutardier, Vincent ^a,b   Turrini, Olivier ^a,c   Calvo, Ezequiel ^d   Ewald, Jacques ^c   Giovannini, Marc ^c   Gasmi, Mohamed ^b   Bories, Erwan ^c   Barthet, Marc ^b   Ouaissi, Mehdi ^e   Goncalves, Anthony ^c   Poizat, Flora ^c   Raoul, Jean Luc ^c   Secq, Veronique ^a,b   Garcia, Stephane ^a,b   Viens, Patrice ^c   Iovanna, Juan ^a   Dusetti, Nelson ^a   more..

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL NORD   (France)

^c INSTITUT PAOLI CALMETTES   (France)

^d LAVAL UNIVERSITY   (Canada)

^e TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; FIRTECAN; FLUOROURACIL; GEMCITABINE; IRINOTECAN; OXALIPLATIN; TRANSCRIPTOME; ANTINEOPLASTIC AGENT; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CELL HETEROGENEITY; CHEMOSENSITIVITY; CLINICAL ARTICLE; DRUG RESISTANCE; DRUG SENSITIVITY; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; EPITHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION ASSAY; HUMAN; IN VITRO STUDY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS ADENOCARCINOMA; PRIMARY CULTURE; PRIORITY JOURNAL; TRANSCRIPTOMICS; TUMOR BIOPSY; TUMOR XENOGRAFT; ADENOCARCINOMA; ANIMAL; DRUG EFFECTS; DRUG SCREENING; ENDOSCOPY; FINE NEEDLE ASPIRATION BIOPSY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PANCREATIC NEOPLASMS; PATHOLOGY; STAINING; SURVIVAL; TREATMENT OUTCOME; TUMOR CELL CULTURE;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; BIOPSY, FINE-NEEDLE; DRUG RESISTANCE, NEOPLASM; ENDOSCOPY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; PANCREATIC NEOPLASMS; RNA, MESSENGER; STAINING AND LABELING; SURVIVAL ANALYSIS; TRANSCRIPTOME; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84925368518     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.11.029     Document Type: Article

References (40)

1. A. Jemal, T. Murray, A. Samuels, A. Ghafoor, E. Ward, and M.J. Thun Cancer statistics, 2003 CA Cancer J Clin 53 2003 5 26
2. H.L. Kindler, T. Ioka, D.J. Richel, J. Bennouna, R. Letourneau, T. Okusaka, A. Funakoshi, J. Furuse, Y.S. Park, S. Ohkawa, G.M. Springett, H.S. Wasan, P.C. Trask, P. Bycott, A.D. Ricart, S. Kim, and E. Van Cutsem Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study Lancet Oncol 12 2011 256 262
3. M.J. Moore, D. Goldstein, J. Hamm, A. Figer, J.R. Hecht, S. Gallinger, H.J. Au, P. Murawa, D. Walde, R.A. Wolff, D. Campos, R. Lim, K. Ding, G. Clark, T. Voskoglou-Nomikos, M. Ptasynski, and W. Parulekar National Cancer Institute of Canada Clinical Trials G: Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 25 2007 1960 1966
4. E. Van Cutsem, W.L. Vervenne, J. Bennouna, Y. Humblet, S. Gill, J.L. Van Laethem, C. Verslype, W. Scheithauer, A. Shang, J. Cosaert, and M.J. Moore Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer J Clin Oncol 27 2009 2231 2237
5. E. Costello, W. Greenhalf, and J.P. Neoptolemos New biomarkers and targets in pancreatic cancer and their application to treatment Nat Rev Gastroenterol Hepatol 9 2012 435 444
6. A. Vincent, J. Herman, R. Schulick, R.H. Hruban, and M. Goggins Pancreatic cancer Lancet 378 2011 607 620
7. J. Iovanna, M.C. Mallmann, A. Goncalves, O. Turrini, and J.C. Dagorn Current knowledge on pancreatic cancer Front Oncol 2 2012 6
8. T. Conroy, F. Desseigne, M. Ychou, O. Bouche, R. Guimbaud, Y. Becouarn, A. Adenis, J.L. Raoul, S. Gourgou-Bourgade, C. de la Fouchardiere, J. Bennouna, J.B. Bachet, F. Khemissa-Akouz, D. Pere-Verge, C. Delbaldo, E. Assenat, B. Chauffert, P. Michel, C. Montoto-Grillot, and M. Ducreux Groupe Tumeurs Digestives of U, Intergroup P: FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer N Engl J Med 364 2011 1817 1825
9. A. Neesse, P. Michl, K.K. Frese, C. Feig, N. Cook, M.A. Jacobetz, M.P. Lolkema, M. Buchholz, K.P. Olive, T.M. Gress, and D.A. Tuveson Stromal biology and therapy in pancreatic cancer Gut 60 2011 861 868
10. F.S. Schreiber, T.B. Deramaudt, T.B. Brunner, M.I. Boretti, K.J. Gooch, D.A. Stoffers, E.J. Bernhard, and A.K. Rustgi Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogene Gastroenterology 127 2004 250 260
11. J.M. Chirgwin, A.E. Przybyla, R.J. MacDonald, and W.J. Rutter Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease Biochemistry 18 1979 5294 5299
12. R.A. Irizarry, B. Hobbs, F. Collin, Y.D. Beazer-Barclay, K.J. Antonellis, U. Scherf, and T.P. Speed Exploration, normalization, and summaries of high density oligonucleotide array probe level data Biostatistics 4 2003 249 264
13. R. Martinez-Garcia, D. Juan, A. Rausell, M. Munoz, N. Banos, C. Menendez, P.P. Lopez-Casas, D. Rico, A. Valencia, and M. Hidalgo Transcriptional dissection of pancreatic tumors engrafted in mice Genome Med 6 2014 27
14. M. Ishikawa, K. Yoshida, Y. Yamashita, J. Ota, S. Takada, H. Kisanuki, K. Koinuma, Y.L. Choi, R. Kaneda, T. Iwao, K. Tamada, K. Sugano, and H. Mano Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells Cancer Sci 96 2005 387 393
15. M. Buchholz, M. Braun, A. Heidenblut, H.A. Kestler, G. Kloppel, W. Schmiegel, S.A. Hahn, J. Luttges, and T.M. Gress Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions Oncogene 24 2005 6626 6636
16. A. Abdollahi, C. Schwager, J. Kleeff, I. Esposito, S. Domhan, P. Peschke, K. Hauser, P. Hahnfeldt, L. Hlatky, J. Debus, J.M. Peters, H. Friess, J. Folkman, and P.E. Huber Transcriptional network governing the angiogenic switch in human pancreatic cancer Proc Natl Acad Sci U S A 104 2007 12890 12895
17. C. Cavard, A. Audebourg, F. Letourneur, V. Audard, F. Beuvon, N. Cagnard, B. Radenen, P. Varlet, M.C. Vacher-Lavenu, C. Perret, and B. Terris Gene expression profiling provides insights into the pathways involved in solid pseudopapillary neoplasm of the pancreas J Pathol 218 2009 201 209
18. I. Abiatari, T. DeOliveira, V. Kerkadze, C. Schwager, I. Esposito, N.A. Giese, P. Huber, F. Bergman, A. Abdollahi, H. Friess, and J. Kleeff Consensus transcriptome signature of perineural invasion in pancreatic carcinoma Mol Cancer Ther 8 2009 1494 1504
19. G. Verma, H. Bhatia, and M. Datta Gene expression profiling and pathway analysis identify the integrin signaling pathway to be altered by IL-1beta in human pancreatic cancer cells: role of JNK Cancer Lett 320 2012 86 95
20. R. Marcotte, K.R. Brown, F. Suarez, A. Sayad, K. Karamboulas, P.M. Krzyzanowski, F. Sircoulomb, M. Medrano, Y. Fedyshyn, J.L. Koh, D. van Dyk, B. Fedyshyn, M. Luhova, G.C. Brito, F.J. Vizeacoumar, F.S. Vizeacoumar, A. Datti, D. Kasimer, A. Buzina, P. Mero, C. Misquitta, J. Normand, M. Haider, T. Ketela, J.L. Wrana, R. Rottapel, B.G. Neel, and J. Moffat Essential gene profiles in breast, pancreatic, and ovarian cancer cells Cancer Discov 2 2012 172 189
21. W.Y. Wang, C.C. Hsu, T.Y. Wang, C.R. Li, Y.C. Hou, J.M. Chu, C.T. Lee, M.S. Liu, J.J. Su, K.Y. Jian, S.S. Huang, S.S. Jiang, Y.S. Shan, P.W. Lin, Y.Y. Shen, M.T. Lee, T.S. Chan, C.C. Chang, C.H. Chen, I.S. Chang, Y.L. Lee, L.T. Chen, and K.K. Tsai A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression Gastroenterology 145 2013 1110 1120
22. M. Buchholz, H.A. Kestler, A. Bauer, W. Bock, B. Rau, G. Leder, W. Kratzer, M. Bommer, A. Scarpa, M.K. Schilling, G. Adler, J.D. Hoheisel, and T.M. Gress Specialized DNA arrays for the differentiation of pancreatic tumors Clin Cancer Res 11 2005 8048 8054
23. T.M. Gress, C. Wallrapp, M. Frohme, F. Muller-Pillasch, U. Lacher, H. Friess, M. Buchler, G. Adler, and J.D. Hoheisel Identification of genes with specific expression in pancreatic cancer by cDNA representational difference analysis Genes Chromosomes Cancer 19 1997 97 103
24. T. Crnogorac-Jurcevic, E. Efthimiou, T. Nielsen, J. Loader, B. Terris, G. Stamp, A. Baron, A. Scarpa, and N.R. Lemoine Expression profiling of microdissected pancreatic adenocarcinomas Oncogene 21 2002 4587 4594
25. E.A. Collisson, A. Sadanandam, P. Olson, W.J. Gibb, M. Truitt, S. Gu, J. Cooc, J. Weinkle, G.E. Kim, L. Jakkula, H.S. Feiler, A.H. Ko, A.B. Olshen, K.L. Danenberg, M.A. Tempero, P.T. Spellman, D. Hanahan, and J.W. Gray Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy Nat Med 17 2011 500 503
26. U. Lehmann, and H. Kreipe Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies Methods 25 2001 409 418
27. T.A. Sohn, C.J. Yeo, J.L. Cameron, L. Koniaris, S. Kaushal, R.A. Abrams, P.K. Sauter, J. Coleman, R.H. Hruban, and K.D. Lillemoe Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators J Gastrointest Surg 4 2000 567 579
28. R.J. Geer, and M.F. Brennan Prognostic indicators for survival after resection of pancreatic adenocarcinoma Am J Surg 165 1993 68 72 discussion-3
29. D.D. You, H.G. Lee, J.S. Heo, S.H. Choi, and D.W. Choi Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma J Gastrointest Surg 13 2009 1699 1706
30. H.J. Moon, J.Y. An, J.S. Heo, S.H. Choi, J.W. Joh, and Y.I. Kim Predicting survival after surgical resection for pancreatic ductal adenocarcinoma Pancreas 32 2006 37 43
31. R.K. Yantiss, H.K. Chang, F.A. Farraye, C.C. Compton, and R.D. Odze Prevalence and prognostic significance of acinar cell differentiation in pancreatic endocrine tumors Am J Surg Pathol 26 2002 893 901
32. N. Wasif, C.Y. Ko, J. Farrell, Z. Wainberg, O.J. Hines, H. Reber, and J.S. Tomlinson Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging' Ann Surg Oncol 17 2010 2312 2320
33. M.M. Rochefort, J.S. Ankeny, B.E. Kadera, G.W. Donald, W. Isacoff, Z.A. Wainberg, O.J. Hines, T.R. Donahue, H.A. Reber, and J.S. Tomlinson Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system Ann Surg Oncol 20 2013 4322 4329
34. S. Yachida, C.M. White, Y. Naito, Y. Zhong, J.A. Brosnan, A.M. Macgregor-Das, R.A. Morgan, T. Saunders, D.A. Laheru, J.M. Herman, R.H. Hruban, A.P. Klein, S. Jones, V. Velculescu, C.L. Wolfgang, and C.A. Iacobuzio-Donahue Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors Clin Cancer Res 18 2012 6339 6347
35. I. Garrido-Laguna, M. Uson, N.V. Rajeshkumar, A.C. Tan, E. de Oliveira, C. Karikari, M.C. Villaroel, A. Salomon, G. Taylor, R. Sharma, R.H. Hruban, A. Maitra, D. Laheru, B. Rubio-Viqueira, A. Jimeno, and M. Hidalgo Tumor engraftment in nude mice and enrichment in stroma-related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer Clin Cancer Res 17 2011 5793 5800
36. E. Raymond, S. Faivre, J.M. Woynarowski, and S.G. Chaney Oxaliplatin: mechanism of action and antineoplastic activity Semin Oncol 25 1998 4 12
37. D.M. Thomas, and J.R. Zalcberg 5-fluorouracil: a pharmacological paradigm in the use of cytotoxics Clin Exp Pharmacol Physiol 25 1998 887 895
38. V.R. Penchev, Z.A. Rasheed, A. Maitra, and W. Matsui Heterogeneity and targeting of pancreatic cancer stem cells Clin Cancer Res 18 2012 4277 4284
39. H. Kamiyama, S. Rauenzahn, J.S. Shim, C.A. Karikari, G. Feldmann, L. Hua, M. Kamiyama, F.W. Schuler, M.T. Lin, R.M. Beaty, B. Karanam, H. Liang, M.E. Mullendore, G. Mo, M. Hidalgo, E. Jaffee, R.H. Hruban, H.A. Jinnah, R.B. Roden, A. Jimeno, J.O. Liu, A. Maitra, and J.R. Eshleman Personalized chemotherapy profiling using cancer cell lines from selectable mice Clin Cancer Res 19 2013 1139 1146
40. Y. Cui, J.A. Brosnan, A.L. Blackford, S. Sur, R.H. Hruban, K.W. Kinzler, B. Vogelstein, A. Maitra, L.A. Diaz Jr., C.A. Iacobuzio-Donahue, and J.R. Eshleman Genetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity Clin Cancer Res 18 2012 6519 6530